These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33629514)

  • 1. Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.
    Shen Y; Gao L; Jiang S; Liu J; Cheng W; Shou H
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):70-75. PubMed ID: 33629514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.
    Ni J; Zhu T; Zhao L; Che F; Chen Y; Shou H; Yu A
    Clin Transl Oncol; 2015 Oct; 17(10):835-9. PubMed ID: 26260911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological significance of ubiquitin-conjugating enzyme E2C, leucine-rich repeated-containing G protein-coupled receptor, WW domain-containing oxidoreductase, and vasculogenic mimicry in invasive breast carcinoma.
    Shen R; Wu T; Huang P; Shao Q; Chen M
    Medicine (Baltimore); 2019 Apr; 98(16):e15232. PubMed ID: 31008954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype.
    Wang X; Chao L; Ma G; Chen L; Zang Y; Sun J
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):271-8. PubMed ID: 20401669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.
    Lin YH; Hsiao YH; Wu WJ; Yang SF; Hsu CF; Kang YT; Wang PH
    Int J Med Sci; 2018; 15(10):1005-1013. PubMed ID: 30013442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies.
    Aldaz CM; Ferguson BW; Abba MC
    Biochim Biophys Acta; 2014 Aug; 1846(1):188-200. PubMed ID: 24932569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan.
    Li JP; Chang JT; Ju PC; Hsieh MH; Chao YH; Tsao TC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation of the expressions of WWOX, LGR5 and vasohibin-1 in epithelial ovarian cancer and their clinical significance.
    Yu L; Mao X; Wu S; Zhou L; Song W; Gong X; Wang D
    Int J Clin Exp Pathol; 2019; 12(1):327-336. PubMed ID: 31933749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (BMI-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver Cancer Tissue and Normal Liver Tissue.
    Yu J; Hu M; Chen W; Wen Z
    Med Sci Monit; 2018 Sep; 24():6673-6679. PubMed ID: 30242144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
    Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
    Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of WW domain-containing oxidoreductase expression in the progression and development of gastric carcinoma: clinical and histopathologic correlations.
    Maeda N; Semba S; Nakayama S; Yanagihara K; Yokozaki H
    Virchows Arch; 2010 Oct; 457(4):423-32. PubMed ID: 20737170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of WWOX protein in epithelial ovarian cancer: a clinicopathologic and immunohistochemical study.
    Lan C; Chenggang W; Yulan B; Xiaohui D; Junhui Z; Xiao W
    Int J Gynecol Pathol; 2012 Mar; 31(2):125-32. PubMed ID: 22317867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
    Kurek KC; Del Mare S; Salah Z; Abdeen S; Sadiq H; Lee SH; Gaudio E; Zanesi N; Jones KB; DeYoung B; Amir G; Gebhardt M; Warman M; Stein GS; Stein JL; Lian JB; Aqeilan RI
    Cancer Res; 2010 Jul; 70(13):5577-86. PubMed ID: 20530675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer.
    Seabra MAL; Cândido EB; Vidigal PVT; Lamaita RM; Rodrigues AN; Silva Filho ALD
    Rev Bras Ginecol Obstet; 2018 Feb; 40(2):79-85. PubMed ID: 29310145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.
    Abu-Odeh M; Bar-Mag T; Huang H; Kim T; Salah Z; Abdeen SK; Sudol M; Reichmann D; Sidhu S; Kim PM; Aqeilan RI
    J Biol Chem; 2014 Mar; 289(13):8865-80. PubMed ID: 24550385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ORAOV1, CD133 and WWOX correlate with metastasis and prognosis in gastric adenocarcinoma.
    Lu G; Zhou L; Song W; Wu S; Zhu B; Wang D
    Int J Clin Exp Pathol; 2017; 10(8):8916-8924. PubMed ID: 31966760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.
    Janczar S; Nautiyal J; Xiao Y; Curry E; Sun M; Zanini E; Paige AJ; Gabra H
    Cell Death Dis; 2017 Jul; 8(7):e2955. PubMed ID: 28749468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
    Chen X; Li P; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.
    Zhou C; Chen W; Sun J; Atyah M; Yin Y; Zhang W; Guo L; Ye Q; Dong Q; Shi Y; Ren N
    Cancer Med; 2018 Jul; 7(7):3031-3043. PubMed ID: 29905011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.